Shigemi Sasawatari

537 total citations
16 papers, 442 citations indexed

About

Shigemi Sasawatari is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shigemi Sasawatari has authored 16 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Shigemi Sasawatari's work include CAR-T cell therapy research (4 papers), Mitochondrial Function and Pathology (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Shigemi Sasawatari is often cited by papers focused on CAR-T cell therapy research (4 papers), Mitochondrial Function and Pathology (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Shigemi Sasawatari collaborates with scholars based in Japan and Canada. Shigemi Sasawatari's co-authors include Toshihiko Toyofuku, Atsushi Kumanogoh, Yuki Okamoto, Noriko Toyama‐Sorimachi, Eiji Kasumi, Norihiro Kato, Keiko Morimoto, Rieko Yanobu‐Takanashi, Senji Shirasawa and Tadashi Okamura and has published in prestigious journals such as The Journal of Experimental Medicine, The EMBO Journal and Blood.

In The Last Decade

Shigemi Sasawatari

16 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigemi Sasawatari Japan 11 205 177 92 83 70 16 442
Xiaodong Zhu China 8 183 0.9× 200 1.1× 137 1.5× 84 1.0× 62 0.9× 19 461
Vikas Singh India 12 305 1.5× 120 0.7× 71 0.8× 37 0.4× 56 0.8× 16 493
Sigal B. Kofman United States 4 367 1.8× 257 1.5× 115 1.3× 66 0.8× 20 0.3× 6 629
Kezhou Zhu China 9 456 2.2× 167 0.9× 92 1.0× 192 2.3× 83 1.2× 16 624
Manoel Jacobsen Brazil 4 266 1.3× 77 0.4× 46 0.5× 62 0.7× 37 0.5× 4 403
Yossi Gottfried Israel 10 459 2.2× 65 0.4× 126 1.4× 83 1.0× 76 1.1× 11 604
Xia Huang China 5 617 3.0× 104 0.6× 66 0.7× 144 1.7× 47 0.7× 10 759
Chengzhou Mao China 8 143 0.7× 174 1.0× 40 0.4× 48 0.6× 102 1.5× 16 448
Hanna Ćwiklińska Poland 11 338 1.6× 220 1.2× 38 0.4× 34 0.4× 46 0.7× 13 575

Countries citing papers authored by Shigemi Sasawatari

Since Specialization
Citations

This map shows the geographic impact of Shigemi Sasawatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigemi Sasawatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigemi Sasawatari more than expected).

Fields of papers citing papers by Shigemi Sasawatari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigemi Sasawatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigemi Sasawatari. The network helps show where Shigemi Sasawatari may publish in the future.

Co-authorship network of co-authors of Shigemi Sasawatari

This figure shows the co-authorship network connecting the top 25 collaborators of Shigemi Sasawatari. A scholar is included among the top collaborators of Shigemi Sasawatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigemi Sasawatari. Shigemi Sasawatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sasawatari, Shigemi, et al.. (2021). The inhibitory NK receptor Ly49Q protects plasmacytoid dendritic cells from pyroptotic cell death. Molecular Immunology. 135. 217–225. 4 indexed citations
2.
Toyofuku, Toshihiko, et al.. (2020). LRRK 2 regulates endoplasmic reticulum–mitochondrial tethering through the PERK ‐mediated ubiquitination pathway. The EMBO Journal. 39(18). 9 indexed citations
3.
Sasawatari, Shigemi, Yoshihiro Matsuno, Kanako C. Hatanaka, et al.. (2020). Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients. Cancers. 12(10). 2735–2735. 6 indexed citations
4.
Sasawatari, Shigemi, Yuki Okamoto, Atsushi Kumanogoh, & Toshihiko Toyofuku. (2020). Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells. The Journal of Immunology. 204(5). 1373–1385. 31 indexed citations
5.
Toyofuku, Toshihiko, et al.. (2019). LRRK 2 regulates endoplasmic reticulum–mitochondrial tethering through the PERK ‐mediated ubiquitination pathway. The EMBO Journal. 39(2). e100875–e100875. 89 indexed citations
6.
Nakamura, Yuki, Shigeru Miyagawa, Shohei Yoshida, et al.. (2019). Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model. Scientific Reports. 9(1). 10840–10840. 12 indexed citations
7.
Sasawatari, Shigemi, et al.. (2016). Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research. Molecular Therapy — Oncolytics. 3. 16024–16024. 21 indexed citations
8.
Toyofuku, Toshihiko, Keiko Morimoto, Shigemi Sasawatari, & Atsushi Kumanogoh. (2015). Leucine-Rich Repeat Kinase 1 Regulates Autophagy through Turning On TBC1D2-Dependent Rab7 Inactivation. Molecular and Cellular Biology. 35(17). 3044–3058. 45 indexed citations
9.
Sasawatari, Shigemi, Tadashi Okamura, Eiji Kasumi, et al.. (2011). The Solute Carrier Family 15A4 Regulates TLR9 and NOD1 Functions in the Innate Immune System and Promotes Colitis in Mice. Gastroenterology. 140(5). 1513–1525. 89 indexed citations
10.
Ishikawa, Kaori, Noriko Toyama‐Sorimachi, Kazuto Nakada, et al.. (2010). The innate immune system in host mice targets cells with allogenic mitochondrial DNA. The Journal of Experimental Medicine. 207(11). 2297–2305. 37 indexed citations
11.
Sasawatari, Shigemi, Choji Taya, Hiromichi Yonekawa, et al.. (2010). The Ly49Q Receptor Plays a Crucial Role in Neutrophil Polarization and Migration by Regulating Raft Trafficking. Immunity. 32(2). 200–213. 30 indexed citations
12.
Kasumi, Eiji, Shigemi Sasawatari, Kenji Itoh, et al.. (2009). Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q. Blood. 114(8). 1518–1527. 27 indexed citations
13.
Sasawatari, Shigemi, et al.. (2006). Efficient priming and expansion of antigen‐specific CD8+ T cells by a novel cell‐based artificial APC. Immunology and Cell Biology. 84(6). 512–521. 28 indexed citations
14.
Sasawatari, Shigemi, et al.. (2004). Effect of PCB-126 on Intracellular Accumulation and Transepithelial Transport of Vinblastine in LLC-PK1 and Its Transformant Cells Expressing Human P-Glycoprotein. Journal of Veterinary Medical Science. 66(9). 1079–1085. 2 indexed citations
15.
Fujise, Hiroshi, Shigemi Sasawatari, Takeshi Annoura, Teruo Ikeda, & Kazumitsu Ueda. (2004). 3, 3, 4, 4, 5‐Pentachlorobiphenyl Inhibits Drug Efflux Through P‐Glycoprotein in KB‐3 Cells Expressing Mutant Human P‐Glycoprotein. BioMed Research International. 2004(3). 137–142. 2 indexed citations
16.
Fujise, Hiroshi, Takeshi Annoura, Shigemi Sasawatari, Teruo Ikeda, & Kazumitsu Ueda. (2002). Transepithelial transport and cellular accumulation of steroid hormones and polychlorobiphenyl in porcine kidney cells expressed with human P-glycoprotein. Chemosphere. 46(9-10). 1505–1511. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026